Form 4: Oncology Institute CFO Sells Shares to Cover Tax Obligations

The Chief Financial Officer of Oncology Institute, Robert Ross Carter, sold 235 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Summary

• Robert Ross Carter, the Chief Financial Officer of Oncology Institute, Inc., sold 235 shares of Class A Common Stock on November 20, 2024.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• The shares were sold at a volume-weighted average price of $0.136, with actual prices ranging from $0.136 to $0.168.
• Following the transaction, Carter directly owns 31,759 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: This is a routine transaction for an executive to cover tax obligations and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across publicly traded companies.
• The volume weighted average price of $0.136 is specific to this transaction and would need to be compared to the overall market price of TOI stock at the time of the transaction to assess if it was a fair price.
• The number of shares sold is relatively small compared to the total shares owned by the CFO, which is typical for these types of transactions.

Stakeholder Impact

• The sale of shares by the CFO has a minimal impact on shareholders as it is a small transaction and is a common practice.

Key Dates

Keywords

Oncology Institute, Robert Ross Carter, CFO, Class A Common Stock, stock sale, restricted stock units, tax obligations, Form 4, insider trading